Prognostic and Predictive Value of KRAS Mutation in NSCLC

被引：1
|
作者：
Yamamoto, Satomi [1 ]
Washington, Laurie [1 ]
Komiya, Takefumi [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Med Oncol, Fairway, KS 66205 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2016年 / 11卷 / 10期
关键词：
D O I：
10.1016/j.jtho.2016.04.035
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E128 / +
页数：2
相关论文
共 50 条
  • [41] KRAS Mutation as a Resistance Mechanism to BRAF/MEK Inhibition in NSCLC
    Niemantsverdriet, Maarten
    Schuuring, Ed
    ter Elst, Arja
    van der Wekken, Antonie J.
    van Kempen, Leon C.
    van den Berg, Anke
    Groen, Harry J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : E249 - E251
  • [42] Establishing role of KRAS mutation on NSCLC radio-sensitivity
    Bhardwaj, Vikas
    Likhacheva, Anna
    Byers, Lauren A. Byers A.
    Diao, Lixia
    Allen, Pamela K.
    Minna, John D.
    Ihle, Nathan T.
    Powis, Garth
    Das, Amit K.
    Girard, Luc
    Peyton, Michael
    Yordy, John
    Liao, Zhongxing
    Ang, Kian K.
    Story, Michael
    Kalhor, Neda
    Komaki, Ritsuko
    Kim, Edward S.
    Heymach, John V.
    Welsh, James
    CANCER RESEARCH, 2012, 72
  • [43] Predictive value of KRAS mutations in chemoresistant CRC
    Astrid Lièvre
    Pierre Laurent-Puig
    Nature Reviews Clinical Oncology, 2009, 6 : 306 - 307
  • [44] Predictive value of KRAS mutations in chemoresistant CRC
    Lievre, Astrid
    Laurent-Puig, Pierre
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (06) : 306 - 307
  • [45] Predictive and Prognostic Value of CTC Monitoring in Advanced NSCLC Patients Treated with Immune Checkpoint Inhibitors
    Gao, G.
    Li, J.
    Zhou, F.
    Li, W.
    Xiong, A.
    Chen, X.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S730 - S730
  • [46] Radiomics features as predictive and prognostic biomarkers in NSCLC
    Bortolotto, Chandra
    Lancia, Andrea
    Stelitano, Chiara
    Montesano, Marianna
    Merizzoli, Elisa
    Agustoni, Francesco
    Stella, Giulia
    Preda, Lorenzo
    Filippi, Andrea Riccardo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (03) : 257 - 266
  • [47] Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2
    Boeckx, Nele
    Peeters, Marc
    Van Camp, Guy
    Pauwels, Patrick
    de Beeck, Ken Op
    Deschoolmeester, Vanessa
    DRUGS, 2015, 75 (15) : 1739 - 1756
  • [48] Prognostic and Predictive Value of RAS Gene Mutations in Colorectal Cancer: Moving Beyond KRAS Exon 2
    Nele Boeckx
    Marc Peeters
    Guy Van Camp
    Patrick Pauwels
    Ken Op de Beeck
    Vanessa Deschoolmeester
    Drugs, 2015, 75 : 1739 - 1756
  • [49] Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma
    Tao, Luwei
    Miao, Ruoyu
    Mekhail, Tarek
    Sun, Jingxin
    Meng, Lingbin
    Fang, Cheng
    Guan, Jian
    Jain, Akriti
    Du, Yuan
    Allen, Amanda
    Rzeszutko, Brenda L.
    Socinski, Mark A.
    Chang, Chung-Che
    CLINICAL LUNG CANCER, 2020, 22 (04) : E506 - E511
  • [50] Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers
    de Cuba, E. M. V.
    Snaebjornsson, P.
    Heideman, D. A. M.
    van Grieken, N. C. T.
    Bosch, L. J. W.
    Fijneman, R. J. A.
    Belt, E.
    Bril, H.
    Stockmann, H. B. A. C.
    Hooijberg, E.
    Punt, C. J. A.
    Koopman, M.
    Nagtegaal, I. D.
    Coupe, V. H. M.
    Carvalho, B.
    Meijer, G. A.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (05) : 1139 - 1145
12345